Showing results (1461-1470 of 3,896) with videos related to
Sort By:
Pageof 390
Disease Markers|September 27, 2018
Spexin Levels Are Associated with Metabolic Syndrome ComponentsNasser M Al-Daghri, Amal Alenad, Hazim Al-Hazmi, et al.Disease Markers|October 2, 2018
Testing a Combination of Markers of Systemic Redox Status as a Possible Tool for the Diagnosis of Late Onset Alzheimer's DiseaseGiovanni Zuliani, Angelina Passaro, Cristina Bosi, et al.Disease Markers|October 18, 2018
Contribution of Interleukin-10-592 (-590, -597) C>A Polymorphisms to Periodontitis Susceptibility: An Updated Meta-Analysis Based on 18 Case-Control StudiesYao Li, Ge Feng, Yuejia Deng, et al.Disease Markers|July 8, 2017
Eg5 Overexpression Is Predictive of Poor Prognosis in Hepatocellular Carcinoma PatientsCan Liu, Nan Zhou, Jieying Li, et al.Disease Markers|June 1, 2018
CRISPR/Cas9 Genome Editing of Epidermal Growth Factor Receptor Sufficiently Abolished Oncogenicity in Anaplastic Thyroid CancerLi-Chi Huang, Ka-Wai Tam, Wei-Ni Liu, et al.Disease Markers|June 1, 2018
CXCR4/CXCL12 Signaling and Protumor Macrophages in Primary Tumors and Sentinel Lymph Nodes Are Involved in Luminal B Breast Cancer ProgressionCarlotta Raschioni, Giulia Bottai, Andrea Sagona, et al.Disease Markers|June 1, 2018
Metabolomics of Hydrazine-Induced Hepatotoxicity in Rats for Discovering Potential BiomarkersZhuoling An, Chao Li, Yali Lv, et al.Disease Markers|April 6, 2018
The Pathophysiological Mechanisms and the Quest for Biomarkers in Psoriasis, a Stress-Related Skin DiseaseMircea Tampa, Maria-Isabela Sarbu, Madalina-Irina Mitran, et al.Disease Markers|June 1, 1987
DR beta Taq I restriction fragment length polymorphism (RFLP) associated with insulin dependent diabetes mellitus (IDDM)T W Hodge, B O Barger, R T ActonDisease Markers|December 1, 1987
DQ beta restriction fragment length polymorphism and its relationship to insulin dependent diabetes mellitusJ A Sachs, P G Cassell, H Festenstein, et al.Pageof 390